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Abstract
Background: Analgesia for neonatal circumcision was recently advocated for every male infant,
and its use is considered essential by the American Academy of Pediatrics. We compared the post-
operative analgesic quality of bupivacaine to that of lidocaine for achieving dorsal penile nerve block
(DPNB) when performing neonatal circumcision.
Methods: Data were obtained from 38 neonates following neonatal circumcision. The infants had
received DPNB analgesia with either lidocaine or bupivacaine. The outcome variable was the
administration by the parents of acetaminophen during the ensuing 24 hours.
Results: Seventeen infants received lidocaine and 19 received bupivacaine DPNB. Ten infants in
the lidocaine group (59%) were given acetaminophen following circumcision compared to only 3
(16%) in the bupivacaine group (P < 0.01). Regression analysis showed that the only significant
variable associated with the need for acetaminophen was the use of lidocaine (R2 = 20.6; P = 0.006).
Conclusion: DPNB with bupivacaine for neonatal circumcision apparently confers better analgesia
than lidocaine as judged by the requirement of acetaminophen over the ensuing 24-hour period.
Background
The issue of whether or not to circumcise a male infant
one week after birth (when medically permissible) is
essentially nonexistent in Israel. In an atmosphere of cel-
ebration and feasting, the procedure ("brit mila") has
been carried out for over 4,000 years by non-physicians
("mohelim"). A mohel uses no anesthesia when perform-
ing the circumcision. The baby is given a few drops of sac-
ramental wine and the mohel applies tight bandaging to
the wound. The past few years, however, have witnessed a
small but growing trend of young couples who seek to
have their newborns circumcised by doctors using some
kind of anesthesia in order to obviate the baby's pain and
discomfort as well as their own anxiety. This cultural
change has elicited interest among Israeli doctors in seek-
ing optimal management of their newborn patients.
Anesthesia is not routinely administered for neonatal cir-
cumcision for a variety of reasons, among them the rela-
tively short duration of the intervention, the perceived
lack of importance of the pain, and concerns of toxicity
from the medications [1]. It is now recognized that
neonates are capable of both perceiving and exhibiting
reproducible responses to pain, and that pain in neonates
may have long-term effects (e.g., "pain memories") [2,3].
The routine use of analgesia during neonatal circumcision
is now considered essential by the American Academy of
Pediatrics [4].
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A topical application of eutectic mixture of the local anes-
thetics, lidocaine and prilocaine (EMLA, Astra Pharma
Inc. Sweden) had achieved considerable popularity for its
ability to diminish pain associated with circumcision. In a
review of the Cochrane database [5], however, its use was
not shown to have any special advantage over other anal-
gesic techniques with proven efficacy, such as regional
nerve block with local anesthetic medications (e.g., lido-
caine injection). We had been using lidocaine for dorsal
penile nerve block (DPNB) in our service, and recently
introduced bupivacaine because it has the important
advantage of a longer duration of action compared to
other local anesthetics [6]. In order to evaluate the clinical
significance of this modification, we used the requirement
of post-operative analgesia as a tool to assess long-term
analgesic efficacy of analgesic medications in general [7],
as well as specifically the requirement of acetaminophen
after neonatal circumcision [8]. In the current study, we
evaluated the duration of the long-term analgesic effect of
bupivacaine in infants undergoing neonatal circumcision.
We hypothesized that infants treated with bupivacaine
will require less acetaminophen than infants treated with
lidocaine.
Methods
All male infants under the age of 2.5 months with normal
penile anatomy were eligible for the study. By design, we
excluded the infants with abnormal penile anatomy (e.g.,
hypospadias), those whose parents did not apply topical
EMLA cream as instructed or when parents did not keep
the scheduled follow-up appointment. The circumcision
was performed by a board certified neonatologist and a
board certified anesthesiologist in an office setting
equipped with all necessary resuscitation equipment. Par-
ents were instructed to apply approximately 2.5 grams of
EMLA cream on the shaft of the penis and 1 cm around its
base one hour prior to the appointed time for circumci-
sion. In order to avoid absorption of the EMLA cream into
the disposable diaper, parents were instructed to apply a
20 × 20 cm piece of household plastic wrap on the inside
of the disposable diaper over the penis. Upon arrival to
the office, the infants received 25–30 mg/kg acetami-
nophen, either orally or per-rectum, as preemptive analge-
sia (Acamoli syrup 120 mg/ml or Acamoli suppository
150 mg, Teva Medical, Petah Tikva, Israel). Oral doses of
40/kg body weight of acetaminophen have been used for
post-operative pain treatment in infants [9]. Since aceta-
minophen has a large volume of distribution, a relatively
large initial dose is required irrespective of whether treat-
ment is administered orally or rectally. Tréluyer et al.
found that the optimum oral dose was 30 mg/kg [10].
From 0.3–0.5 ml 30% sucrose-solution was given orally
just prior to the analgesic injection [11]. All study infants
received an injection of lidocaine 1% 6–8 mg as a subcu-
taneous ring block to the base of the penis by means of a
hypodermic 27 G beveled needle (Becton Dickinson,
Drogheda, Ireland) [12]. The infants were then injected
with either lidocaine 1% (Ezracaine 1%, Rafa Laborato-
ries, Jerusalem, Israel) 4–5 mg/kg (the lidocaine group
which was comprised of infants who underwent the cir-
cumcision before May 18, 2003) or bupivacaine 1.5–2
mg/kg (Marcaine, Astra, Sweden), (the bupivacaine group
consisting of infants who were circumcised after May 18,
2003) in a DPNB using a 25 G needle (Becton Dickinson)
[13]. In order to avoid inadvertent intravenous injection,
suction was applied to the syringe handle prior to injec-
tion, ensuring that the tip of the needle was not inside a
blood vessel.
Circumcision was performed 4–5 minutes after analgesia
administration. An additional dose of 0.3–0.5 ml 30%
sucrose solution was dripped orally. The infants lay on a
padded surface and circumcision was performed using the
Mogen circumcision clamp (all procedures were carried
out by S.D.) [14]. The infants were observed for adverse
effects of analgesia or circumcision for at least 15 minutes
and underwent a physical examination.
The parents were given an instruction sheet and verbally
instructed by the physician to administer a dose of 30 mg/
kg liquid acetaminophen 4 hours after the procedure if
they subjectively felt that the infant displayed any signs
they perceive as pain. One repeat dose was also recom-
mended 4 hours after that if symptoms of pain or discom-
fort reappeared. The parents were instructed to contact the
physician if pain persisted thereafter. A follow-up
appointment was scheduled within 2–5 days after the cir-
cumcision, and the number of acetaminophen doses
administered to the infants during the 24-hour period
after the circumcision was routinely recorded. Consent
was obtained from both parents.
Statistical methods included the t-test, Chi-square test,
and regression analysis. Data are presented as mean ± SD.
A P value of <0.05 was considered significant.
Results
Thirty-eight consecutive infants who underwent neonatal
circumcision between March 1 and June 30, 2003 were
included in this study. Four other infants were excluded, 3
because the parents did not apply EMLA cream and one
because his parents failed to keep the scheduled post-cir-
cumcision appointment. Of these 38 infants, 17 had
DPNB with 1% lidocaine and 19 with 0.5% bupivacaine.
There was no significant difference in birthweight (3065 ±
635 g vs. 3081 ± 570 g for the lidocaine and the bupi-
vacaine groups, respectively), postnatal age (13.3 ± 7.2
days vs. 12.9 ± 8.3 days), or weight at circumcision (3256
± 570 g vs. 3285 ± 517 g). None of the studied infantsBMC Pediatrics 2005, 5:12 http://www.biomedcentral.com/1471-2431/5/12
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showed any clinical signs of cardiac or neurological toxic-
ity after either analgesia.
Nine of the seventeen infants in the lidocaine group were
given an additional dose of acetaminophen and another
one received 2 doses (59%). In the bupivacaine group, 1
of the 19 infants received 1 dose and 2 were given two
doses of acetaminophen (16%, χ 2 = 7.2; P < 0.01). None
of the study infants was given more than 2 doses and none
of the parents contacted the physician because they
detected signs that their infant was experiencing pain or
discomfort. Regression analysis, taking into account the
need for acetaminophen as the dependent variable and
the birthweight, current age, current weight and bupi-
vacaine or lidocaine as the administered drug, showed
that only the type of drug was significant in the regression
model (R2 = 20.6; P = 0.006).
Discussion
Infants who were treated with bupivacaine injected as a
DPNB had significantly better post-operative analgesia
compared with lidocaine, as judged by their lower
requirement of acetaminophen 24 hours after circumci-
sion. Despite the recommendation to use 0.5% bupi-
vacaine for DPNB in the previous edition of a major
textbook of regional analgesia [15], a Medline search
failed to identify any reports on the use of bupivacaine in
DPNB for neonatal circumcision.
The use of bupivacaine for pediatric analgesia for circum-
cision was reported in two recently published studies per-
formed on children older than 1 year. A study by Choi et
al [6] compared the use of topical EMLA cream with bupi-
vacaine in a randomized placebo-controlled manner and
concluded that, despite no difference in the score
obtained using a pain scale between the two groups, bupi-
vacaine DPNB resulted in significantly longer analgesia. A
second recently published study by Gauntlett [8] com-
pared bupivacaine in DPNB with caudal bupivacaine with
ketamine in 60 boys and reported no immediate adverse
effects.
The use of bupivacaine may be potentially more hazard-
ous than lidocaine in cases of accidental intravenous
injection. Cardiac toxic effects of high doses or uninten-
tional intravascular injection may lead to high plasma lev-
els and related depression of the myocardium, decreased
cardiac output, heart block, hypotension, bradycardia,
ventricular arrhythmias and cardiac arrest [16]. Adverse
central nervous system effects include restlessness, anxi-
ety, dizziness, tinnitus, blurred vision or tremors and
sometimes convulsions [16]. The safety of DPNB was
recently studied in 3,909 pediatric patients undergoing
circumcision. The authors did not report the type of med-
ication and dosage that had been used and also failed to
note if there had been any patients with accidental intra-
venous injection of the local anesthetic medication [17].
An additional study of neonatal circumcision with DPNB
in 491 patients found that the only complication was
bruising at the injection site in 11% of patients [18]. The
type of drug used in this study was not specified in this
study.
The mechanism of the reduced requirement of acetami-
nophen after bupivacaine injection is not clear. High pro-
tein binding, better lipid solubility and high pKa all
contribute to the longer duration of analgesia, reported
mean elimination half-life of 8.1 hours versus 3.2 hours
of lidocaine [19]. It is possible that, in addition, the longer
period of blocked nociception is sufficient to blunt the
hypersensitization associated with persistent postopera-
tive pain input. This secondary hyperalgesia is mediated
in the spinal cord and contributes to postoperative pain
[20].
Some potential limitations of our study should be men-
tioned. The data for this study were collected retrospec-
tively and patient allocation was in a sequential fashion.
This approach may introduce a potential bias: for exam-
ple, while it is theoretically possible that the performance
of the analgesia improved over time, thereby resulting in
a better outcome in the bupivacaine group, the study was
performed during a relatively short time frame and this
drawback is not very likely. Secondly, the assessment of
pain in the infants was done subjectively by the parents.
Crying may have been misinterpreted by the parents as
pain, but could have stemmed from other reasons, and
could have been managed by some of the parents by
modalities other than acetaminophen (e.g., feeding, dia-
per changing, rocking the infant). Since the parents in
both groups were instructed in an identical manner (ver-
bal and written instructions) to give acetaminophen if
they felt that their son was in pain, this potential bias was
probably not significant.
Conclusion
Given the rarity of accidental intravenous injection and its
longer analgesic effect, we conclude that bupivacaine is
superior to lidocaine for DPNB when performing neona-
tal circumcision.
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